Year |
Citation |
Score |
2020 |
Barre A, Naudot M, Colin F, Sevestre H, Collet L, Devauchelle B, Lack S, Marolleau JP, Le Ricousse S. An Alginate-Based Hydrogel with a High Angiogenic Capacity and a High Osteogenic Potential. Bioresearch Open Access. 9: 174-182. PMID 32642332 DOI: 10.1089/Biores.2020.0010 |
0.311 |
|
2015 |
Leclerc E, Hamon J, Claude I, Jellali R, Naudot M, Bois F. Investigation of acetaminophen toxicity in HepG2/C3a microscale cultures using a system biology model of glutathione depletion. Cell Biology and Toxicology. 31: 173-85. PMID 25956491 DOI: 10.1007/S10565-015-9302-0 |
0.599 |
|
2014 |
Baudoin R, Alberto G, Legendre A, Paullier P, Naudot M, Fleury MJ, Jacques S, Griscom L, Leclerc E. Investigation of expression and activity levels of primary rat hepatocyte detoxication genes under various flow rates and cell densities in microfluidic biochips. Biotechnology Progress. 30: 401-10. PMID 24376233 DOI: 10.1002/Btpr.1857 |
0.665 |
|
2014 |
Naudot M, Paullier P, Dargent T, Senez V, Kharboutly Z, Claude I, Leclerc E. Characterisation of early HepG2/3a cell response to a microfluidic culture in liver biochips using multi-parametric real time image processing Sensors and Actuators B: Chemical. 199: 433-445. DOI: 10.1016/J.Snb.2014.03.074 |
0.636 |
|
2013 |
Legendre A, Baudoin R, Alberto G, Paullier P, Naudot M, Bricks T, Brocheton J, Jacques S, Cotton J, Leclerc E. Metabolic characterization of primary rat hepatocytes cultivated in parallel microfluidic biochips. Journal of Pharmaceutical Sciences. 102: 3264-76. PMID 23423727 DOI: 10.1002/Jps.23466 |
0.427 |
|
2013 |
Choucha Snouber L, Bunescu A, Naudot M, Legallais C, Brochot C, Dumas ME, Elena-Herrmann B, Leclerc E. Metabolomics-on-a-chip of hepatotoxicity induced by anticancer drug flutamide and Its active metabolite hydroxyflutamide using HepG2/C3a microfluidic biochips. Toxicological Sciences : An Official Journal of the Society of Toxicology. 132: 8-20. PMID 22843567 DOI: 10.1093/Toxsci/Kfs230 |
0.66 |
|
Show low-probability matches. |